U.S., July 12 -- ClinicalTrials.gov registry received information related to the study (NCT07060157) titled 'Comparative Efficacy of Resveratrol 1 % Gel and Trichloroacetic Acid 20% in Treatment of Melasma: A Split-face Study' on March 21.

Brief Summary: 1. To evaluate the efficacy and safety of topical resveratrol 1 % gel in treatment of melasma.

2. To compare between the efficacy of topical resveratrol 1 %gel versrs chemical peeling with TCA 20% in melasma.

Study Start Date: July 22

Study Type: INTERVENTIONAL

Condition: Melasma

Intervention: DRUG: resveratrol 1 % gel

left side of face the patient will be given resveratrol 1 % gel once daily at night (Home use ).

DRUG: TCA20%

left side of face the patient will be given resveratr...